We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App





Abbott Introduces GLP Systems Track Laboratory Automation Solution

By LabMedica International staff writers
Posted on 22 May 2023
Print article
Image: GLP Systems offers global scale and is trusted by more than 25 sites globally (Photo courtesy of Abbott)
Image: GLP Systems offers global scale and is trusted by more than 25 sites globally (Photo courtesy of Abbott)

Abbott (Lake Forest, IL, USA) is participating in EuroMedLab-WorldLab 2023 where it is introducing GLP Systems, an innovative total laboratory automation (TLA) solution, offering proven technology with more flexibility and options to meet high volume needs.

Clinical labs are constantly on the lookout for solutions that can help them process an increasing number of sample tubes more efficiently, while simultaneously reducing costs and maintenance of their systems. A significant objective is to facilitate connectivity with a diverse range of instruments, which would help reduce both complexity and cost, and most importantly, simplify the decision-making process regarding automation. The GLP TLA system, which employs an automated sample delivery track system, handles an impressive 900 samples per hour end-to-end. This automation significantly cuts down turnaround time, positively impacting patient care, especially in critical care units. The system also includes a feature that limits direct contact with patients' blood samples, thus safeguarding the workers. It enhances efficiency through consistent sample management, thereby ensuring a more reliable and speedier laboratory service.

The GLP TLA system can markedly boost the efficacy of laboratory testing. A standout feature of this system is its multi-floor transport capability, which eliminates the boundaries between various departments and floors, thereby expediting the availability of test results for doctors. The GLP TLA system mitigates the risks associated with implementing a long-term solution, thanks to its innovative track design. Labs now have the flexibility to modify their track to accommodate future changes and can optimize floor space by evolving their labs from a 2D to a 3D setup. The system also alleviates the common difficulties associated with adopting a new automation system by minimizing the time needed for track implementation and offering more efficient service and training. The GLP TLA system allows labs to concentrate on crucial tasks by maximizing uptime with infinite redundancy, streamlining workflow, and reducing turnaround time.

Related Links:
Abbott 

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.